Skip to main content

Table 1 Correlation of SPAG5 expression and clinical features of TNBC patients

From: SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer

Variable Overall (N = 42) SPAG5
Low expression (N = 20) High expression (N = 22)  
N % N % N % P
Age, years 0.746
  ≤ 50 20 47.62 9 45.00 11 50.00  
  > 50 22 52.38 11 55.00 11 50.00
Tumor size, cm 0.72
  < 2 21 50.00 9 45.00 12 54.55  
  2 ≤ T < 5 18 42.86 9 45.00 9 40.91
  ≥ 5 3 7.14 2 10.00 1 4.55
Histological grade 0.98
  I/II 23 54.76 11 55.00 12 54.55  
  III 19 45.24 9 45.00 10 45.45
Node status 0.04
 pN0 (none) 22 52.38 12 60.00 10 45.45  
 pN1 (1–3) 8 19.05 3 15.00 5 22.73
 pN2 (4–9) 4 9.52 4 20.00 0 0.00
 pN3 (≥ 10) 7 16.67 1 5.00 6 27.27
 pNX 1 2.38 0 0.00 1 4.55
Local recurrence 0.009
  Absence 35 83.33 20 100.00 15 68.18  
  Presence 7 16.67 0 0.00 7 31.82
Distant metastasis 0.243
  Absence 34 80.95 18 90.00 16 72.73  
  Presence 8 19.05 2 10.00 6 27.27